Akèy › Enfeksyon Sitomegaloviris
Etid klinik pou Enfeksyon Sitomegaloviris ap rekrite nan Etazini
12 etid pou Enfeksyon Sitomegaloviris ap rekrite patisipan nan sit atravè Etazini.
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone
Ap rekriteFaz 3
1 Day – 30 Years · Tout sèks · Mizajou Sep 11, 2026 · NCT07225972Study Evaluating the Efficacy and Safety of Artesunate
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 3, 2026 · NCT06853184R-MVST Cells for Treatment of Viral Infections in Children and Young Adults
Ap rekriteFaz 1
3 Months – 26 Years · Tout sèks · Mizajou Jul 30, 2026 · NCT06926894Ganciclovir Resistant/Refractory Cytomegalovirus Infection in SOT Recipients and HSCT Patients
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT05234723Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jun 11, 2026 · NCT06407232R-MVST Cells for Treatment of Viral Infections
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT05183490T Cell Therapy of Opportunistic Cytomegalovirus Infection
Ap rekriteFaz 1 bonè
3 Months · Tout sèks · Mizajou Oct 22, 2025 · NCT02982902Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant
Ap rekriteFaz 1/2
Laj 1 a 21 · Tout sèks · Mizajou Oct 6, 2025 · NCT03354728Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
Ap rekriteFaz 1/2
1 Month – 65 Years · Tout sèks · Mizajou Aug 14, 2025 · NCT06909110Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
Ap rekriteFaz 2
1 Month – 79 Years · Tout sèks · Mizajou Aug 8, 2025 · NCT03266640Long-Term Outcomes of Children With Congenital CMV in New York State
Ap rekriteEtid obsèvasyon
0 Days – 1 Year · Tout sèks · Mizajou May 13, 2025 · NCT06226558Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients
Ap rekriteFaz 4
Laj 18 a 75 · Tout sèks · Mizajou Apr 10, 2025 · NCT05626530Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.